Showing results (121-130 of 553) with videos related to
Sort By:
Pageof 56
Current Pharmaceutical Design|October 25, 2014
NCRNA combined therapy as future treatment option for cancerCornelia Braicu, Cristina Catana, George A Calin, et al.Journal of Cardiovascular Translational Research|June 19, 2010
MicroRNAs and ultraconserved genes as diagnostic markers and therapeutic targets in cancer and cardiovascular diseasesJulianna K Edwards, Renata Pasqualini, Wadih Arap, et al.Bioinformatics (Oxford, England)|September 10, 2013
targetHub: a programmable interface for miRNA-gene interactionsGaniraju Manyam, Cristina Ivan, George A Calin, et al.Antioxidants & Redox Signaling|October 12, 2013
HypoxamiRs and cancer: from biology to targeted therapyHarriet E Gee, Cristina Ivan, George A Calin, et al.Cancers|September 14, 2024
Non-Coding RNAs in Peritoneal Carcinomatosis: From Bench to BedsideJulia Bohosova, Nida Sarosh Ashraf, Ondrej Slaby, et al.Antioxidants & Redox Signaling|August 11, 2017
The Many Faces of Long Noncoding RNAs in CancerXue Wu, Oana M Tudoran, George A Calin, et al.Cancer Discovery|February 12, 2016
miRNA Deregulation in Cancer Cells and the Tumor MicroenvironmentRajesha Rupaimoole, George A Calin, Gabriel Lopez-Berestein, et al.Molecular & Cellular Oncology|September 18, 2020
Neural reprogramming via microRNAs: the new kid on the p53-deficient blockDeborah A Silverman, George A Calin, Jeffrey N Myers, et al.Oncoimmunology|December 22, 2016
From cell biology to immunology: Controlling metastatic progression of cancer via microRNA regulatory networksJae Hyon Park, Evropi Theodoratou, George A Calin, et al.Mammalian Genome : Official Journal of the International Mammalian Genome Society|March 7, 2006
Mammalian microRNAs: a small world for fine-tuning gene expressionCinzia Sevignani, George A Calin, Linda D Siracusa, et al.Pageof 56